➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Dow
Baxter
AstraZeneca
Medtronic

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

CENOBAMATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cenobamate and what is the scope of patent protection?

Cenobamate is the generic ingredient in one branded drug marketed by Sk Life and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Cenobamate has twenty-two patent family members in eighteen countries.

Summary for CENOBAMATE
International Patents:22
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 6
Clinical Trials: 4
Patent Applications: 7
DailyMed Link:CENOBAMATE at DailyMed
Recent Clinical Trials for CENOBAMATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
SK Life Science, Inc.Phase 3
SK Life SciencePhase 1

See all CENOBAMATE clinical trials

US Patents and Regulatory Information for CENOBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-005 Mar 10, 2020 RX Yes No   Start Trial   Start Trial Y   Start Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-005 Mar 10, 2020 RX Yes No   Start Trial   Start Trial   Start Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-002 Mar 10, 2020 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Mallinckrodt
McKesson
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.